US STOCKS-Wall St closes higher on Citi earnings, healthcare M&A
* Citigroup to pay $7 bln to settle U.S. mortgage probe
* Shire to accept AbbVie takeover offer
* Dow up 0.7 pct; S&P 500 up 0.5 pct; Nasdaq up 0.6 pct (Updates to close)
By Angela Moon
NEW YORK, July 14 (Reuters) - U.S. stocks ended higher on Monday, with the Dow Jones industrial average hitting an intraday record, lifted by Citigroup's better-than-expected earnings and more deals in the healthcare space.
Monday's flurry of mergers and acquisitions activity in the healthcare sector gave investors some confirmation that the U.S. stock market is still attractive. Shire Plc, which develops and sells drugs to treat rare diseases, succumbed to an increased takeover offer of 31 billion pounds($53 billion) from AbbVie Inc on Monday.
U.S.-listed shares of Shire rose 2.1 percent to $254.27 while AbbVie shares slipped 0.2 percent to $54.85.
Generic drugmaker Mylan Inc said it would buy Abbott Laboratories' specialty and branded generics business outside the United States in an all-stock transaction valued at about $5.3 billion. Mylan shares advanced 2.1 percent to $51.24 while Abbott shares rose 1.3 percent to $41.82.
Citigroup Inc shares jumped 3 percent to $48.42 and gave the S&P 500 one of its biggest boosts. The stock rallied after Citigroup reported second-quarter adjusted earnings per share that exceeded the average analyst estimate and agreed to pay $7 billion to settle a U.S. government investigation into mortgage-backed securities. The S&P financial index gained 0.6 percent. Continuación...